ATE264694T1 - Diagnostisches markierungsmittel - Google Patents

Diagnostisches markierungsmittel

Info

Publication number
ATE264694T1
ATE264694T1 AT96901142T AT96901142T ATE264694T1 AT E264694 T1 ATE264694 T1 AT E264694T1 AT 96901142 T AT96901142 T AT 96901142T AT 96901142 T AT96901142 T AT 96901142T AT E264694 T1 ATE264694 T1 AT E264694T1
Authority
AT
Austria
Prior art keywords
group
diagnostic marker
alkyl group
atom
detection system
Prior art date
Application number
AT96901142T
Other languages
English (en)
Inventor
Susumu Ito
Masayuki Nozawa
Masanobu Shiga
Kasumi Sasamoto
Kazuhiro Takesako
Hiroshi Takeuchi
Original Assignee
Daiichi Pure Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pure Chemicals Co Ltd filed Critical Daiichi Pure Chemicals Co Ltd
Application granted granted Critical
Publication of ATE264694T1 publication Critical patent/ATE264694T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/086—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines more than five >CH- groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/801—Drug, bio-affecting and body treating compositions involving antibody or fragment thereof produced by recombinant dna technology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/802—Antibody or antigen-binding fragment thereof that binds gram-positive bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Holo Graphy (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
AT96901142T 1995-01-30 1996-01-30 Diagnostisches markierungsmittel ATE264694T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1228395 1995-01-30
JP22361395 1995-08-31
PCT/JP1996/000169 WO1996023525A1 (en) 1995-01-30 1996-01-30 Diagnostic marker

Publications (1)

Publication Number Publication Date
ATE264694T1 true ATE264694T1 (de) 2004-05-15

Family

ID=26347861

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901142T ATE264694T1 (de) 1995-01-30 1996-01-30 Diagnostisches markierungsmittel

Country Status (10)

Country Link
US (1) US5968479A (de)
EP (1) EP0800831B9 (de)
KR (1) KR100397020B1 (de)
CN (1) CN1093768C (de)
AT (1) ATE264694T1 (de)
AU (1) AU4497096A (de)
CA (1) CA2211470A1 (de)
DE (1) DE69632244T2 (de)
NO (1) NO308895B1 (de)
WO (1) WO1996023525A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028474A1 (en) * 1996-09-19 2002-03-07 Daiichi Pure Chemical Co., Ltd. Composition for immunohistochemical staining
US6293911B1 (en) 1996-11-20 2001-09-25 Olympus Optical Co., Ltd. Fluorescent endoscope system enabling simultaneous normal light observation and fluorescence observation in infrared spectrum
US7179222B2 (en) 1996-11-20 2007-02-20 Olympus Corporation Fluorescent endoscope system enabling simultaneous achievement of normal light observation based on reflected light and fluorescence observation based on light with wavelengths in infrared spectrum
US6027709A (en) * 1997-01-10 2000-02-22 Li-Cor Inc. Fluorescent cyanine dyes
DE19717904A1 (de) 1997-04-23 1998-10-29 Diagnostikforschung Inst Säurelabile und enzymatisch spaltbare Farbstoffkonstrukte zur Diagnostik mit Nahinfrarotlicht und zur Therapie
US6110630A (en) * 1998-06-18 2000-08-29 Beckman Coulter, Inc. Efficient activated cyanine dyes
US8557298B2 (en) 1998-08-06 2013-10-15 Provectus Pharmatech, Inc. Medicaments for chemotherapeutic treatment of disease
JP2000095758A (ja) 1998-09-18 2000-04-04 Schering Ag 近赤外蛍光造影剤および蛍光造影方法
US7547721B1 (en) 1998-09-18 2009-06-16 Bayer Schering Pharma Ag Near infrared fluorescent contrast agent and fluorescence imaging
HUP0204024A2 (en) * 1999-12-15 2003-04-28 Fuji Photo Film Co Ltd Near infrared fluorescent contrast agent and fluorescence imaging
US6190641B1 (en) * 2000-01-18 2001-02-20 Mallinckrodt Inc. Indocyanine dyes
WO2001066153A1 (en) * 2000-03-03 2001-09-13 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US20030223935A1 (en) * 2001-03-05 2003-12-04 Gray Brian D. Fluorescent membrane intercalating probes and methods for their use
CA2424454C (en) * 2000-09-19 2010-07-20 Li-Cor, Inc. Cyanine dyes
US6669926B1 (en) * 2000-10-16 2003-12-30 Mallinckrodt, Inc. Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
US6673334B1 (en) * 2000-10-16 2004-01-06 Mallinkcrodt, Inc. Light sensitive compounds for instant determination of organ function
US6936827B1 (en) 2001-02-21 2005-08-30 The United States Of America As Represented By The Department Of The Interior Detecting device for fluorescent-labeled material
AU2002252459A1 (en) * 2001-03-22 2002-10-08 Minerva Biotechnologies Corporation Customized therapeutics and in situ diagnostics
US6761878B2 (en) 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US20040082863A1 (en) * 2002-03-15 2004-04-29 Mcgreevy James Device and method for the photodynamic diagnosis of tumor tissue
US6972022B1 (en) 2002-03-27 2005-12-06 Michael Griffin Skin-marking device
GB0208989D0 (en) * 2002-04-19 2002-05-29 Amersham Biosciences Uk Ltd Methods for measuring enzyme activity
SE0300631D0 (sv) * 2003-03-10 2003-03-10 Staffan Gunnarsson Transponder med solcell
EP1496050A1 (de) * 2003-07-08 2005-01-12 Roche Diagnostics GmbH Chemilumineszente Verbindungen und deren Verwendung
NO20035682D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av ösofagkreft og Barretts ösofag
NO20035683D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av prostatakreft
NO20035681D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft
US7705150B2 (en) * 2004-02-04 2010-04-27 Biosearch Technologies, Inc. Cyanine dyes
FR2889700B1 (fr) * 2005-08-11 2012-11-23 Synthinnove Lab Marqueurs, leur procede de fabrication et leurs applications
ITSV20060002A1 (it) * 2006-01-19 2007-07-20 Ferrania Technologies Spa Colorante fluorescente di tipo cianinico
TW200738752A (en) 2006-01-31 2007-10-16 Bayer Schering Pharma Ag Modulation of MDL-1 activity for treatment of inflammatory disease
EP1987846B1 (de) * 2006-02-23 2016-07-13 Adeka Corporation Diagnostischer marker
JP2008043396A (ja) * 2006-08-11 2008-02-28 Olympus Corp 内視鏡システム
WO2008027861A1 (en) * 2006-08-30 2008-03-06 Ge Healthcare Bio-Sciences Corp. System and method for characterizing membranes and membrane filtration devices
JP2008148791A (ja) * 2006-12-14 2008-07-03 Olympus Corp 内視鏡システム
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
JP2011506673A (ja) * 2007-12-14 2011-03-03 バイオティウム， インコーポレイテッド 蛍光性化合物
EP2100621A1 (de) 2008-03-10 2009-09-16 mivenion GmbH Polyether-Polyol-Dendron-Konjugate mit Effektormolekülen für biologisches Targeting
CA2758415C (en) 2008-04-14 2019-06-04 The General Hospital Corporation Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
JP5500875B2 (ja) * 2009-01-30 2014-05-21 キヤノン株式会社 新規化合物、該新規化合物を用いたプローブ及び該新規化合物もしくは該プローブを用いた蛍光イメージング用造影剤
EP2435096A1 (de) * 2009-05-27 2012-04-04 Lumicell Diagnostics, Inc. Verfahren und systeme zur räumlichen identifizierung anomaler zellen
US9155471B2 (en) * 2009-05-27 2015-10-13 Lumicell, Inc'. Methods and systems for spatially identifying abnormal cells
CA2766861A1 (en) 2009-07-09 2011-01-13 F. Hoffmann-La Roche Ag In vivo tumor vasculature imaging
WO2011012646A2 (en) 2009-07-28 2011-02-03 F. Hoffmann-La Roche Ag Non-invasive in vivo optical imaging method
US8658434B2 (en) * 2009-10-28 2014-02-25 Biotium, Inc. Fluorescent pyrene compounds
WO2011095311A1 (en) 2010-02-03 2011-08-11 Mivenion Gmbh Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
KR20130036012A (ko) 2010-05-07 2013-04-09 에프. 호프만-라 로슈 아게 생체외 세포의 검출을 위한 진단 방법
US20120171694A1 (en) * 2010-07-30 2012-07-05 Vermillion, Inc. Predictive markers and biomarker panels for ovarian cancer
US9012242B2 (en) 2010-09-20 2015-04-21 Caliper Life Sciences Multivalent fluorescent probes
FR2967675B1 (fr) * 2010-11-24 2015-02-27 Pf Medicament Derives fluorescents de cyanines polyamines en tant que sonde de diagnostic
US9314304B2 (en) 2010-12-08 2016-04-19 Lumicell, Inc. Methods and system for image guided cell ablation with microscopic resolution
WO2012119999A1 (en) 2011-03-07 2012-09-13 F. Hoffmann-La Roche Ag Means and methods for in vivo testing of therapeutic antibodies
EP2683413A1 (de) 2011-03-07 2014-01-15 F.Hoffmann-La Roche Ag In-vivo-auswahl therapeutisch aktiver antikörper
JP2014508537A (ja) 2011-03-25 2014-04-10 アルマック・サイエンシーズ・（スコットランド）・リミテッド 酵素アッセイ
US9592307B2 (en) 2012-07-20 2017-03-14 Canon Kabushiki Kaisha Compound and photoacoustic imaging contrast medium containing the compound
US9517278B2 (en) 2012-07-20 2016-12-13 Canon Kabushiki Kaisha Compound and photoacoustic imaging contrast medium containing the compound
US9675715B2 (en) 2012-07-20 2017-06-13 Canon Kabushiki Kaisha Contrast agent for photoacoustic imaging
CZ304948B6 (cs) * 2013-01-02 2015-02-04 Vysoká škola chemicko-technologická v Praze Využití polymethiniových solí jako senzorů pro nádorové markery
CN105473051B (zh) 2013-03-14 2019-04-30 卢米切拉有限公司 医学成像设备及使用方法
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
JP6652923B2 (ja) * 2013-09-17 2020-02-26 ブレイズ バイオサイエンス， インコーポレイテッド クロロトキシンコンジュゲート及びその使用方法
US11559580B1 (en) * 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
US10111969B2 (en) * 2014-09-17 2018-10-30 Rigshospitalet uPAR targeting peptide for use in peroperative optical imaging of invasive cancer
US12048732B2 (en) 2016-04-15 2024-07-30 Blaze Bioscience, Inc. Methods of treating breast cancer
CN108264475A (zh) * 2016-12-30 2018-07-10 中国科学院深圳先进技术研究院 吲哚菁绿衍生物及制备方法
WO2018132361A1 (en) 2017-01-10 2018-07-19 Sun Chemical Corporation In-line coating weight and radiant energy exposure measurement
US12553830B2 (en) 2023-01-26 2026-02-17 Sun Chemical Corporation Fluorescent ink and imaging system for defect detection on printed photosensitive objects

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627027A (en) * 1986-04-18 1997-05-06 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US4762701A (en) * 1986-10-31 1988-08-09 Smithkline Beckman Corporation In vivo cellular tracking
DE3828360A1 (de) * 1988-08-20 1990-02-22 Stanowsky Alexander Dr Farbstoff-markierter antitumor-antikoerper und verfahren zu seiner herstellung
WO1991018007A1 (en) * 1990-05-15 1991-11-28 Diatron Corporation Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents
GB9014307D0 (en) * 1990-06-27 1990-08-15 Scient Generics Ltd Method of treatment and compositions therefor
JP3354975B2 (ja) * 1992-10-06 2002-12-09 イビデン株式会社 蛍光標識試薬および蛍光免疫測定法
JP3176163B2 (ja) * 1993-01-28 2001-06-11 イビデン株式会社 蛍光標識試薬および蛍光免疫測定法
WO1995002699A1 (en) * 1993-07-17 1995-01-26 Aprogenex, Inc. Analogues of reporter groups as backgroung reducers in hybridization assays
JPH0783925A (ja) * 1993-09-17 1995-03-31 Ibiden Co Ltd 蛍光標識試薬および蛍光免疫測定法
JP3368011B2 (ja) * 1993-10-04 2003-01-20 キヤノン株式会社 核酸検出法

Also Published As

Publication number Publication date
EP0800831B1 (de) 2004-04-21
CN1180316A (zh) 1998-04-29
DE69632244D1 (de) 2004-05-27
WO1996023525A1 (en) 1996-08-08
CN1093768C (zh) 2002-11-06
US5968479A (en) 1999-10-19
KR100397020B1 (ko) 2004-04-29
DE69632244T2 (de) 2005-04-14
EP0800831A1 (de) 1997-10-15
NO973484D0 (no) 1997-07-29
EP0800831B9 (de) 2004-11-10
AU4497096A (en) 1996-08-21
NO308895B1 (no) 2000-11-13
NO973484L (no) 1997-09-30
EP0800831A4 (de) 2000-04-26
CA2211470A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
ATE264694T1 (de) Diagnostisches markierungsmittel
NO174389C (no) Plantebeskyttende triazol- og imidazolforbindelser og anvendelse derav
ATE342896T1 (de) Fluoreszierende proben zur quantitativen bestimmung von zink
ES2094150T3 (es) Derivado de triazina y herbicida que lo contiene a titulo de ingrediente activo.
FI964444A0 (fi) Yhdisteet, jotka sisältävät Michael-akseptorin, erityisesti maleiimi-imidi- tai maleiinihappojohdannaisen, ja jotka on sidottu kromoforiin ja niiden käyttö pitkään kestävissä auringonestokoostumuksissa
ATE79622T1 (de) 1,4-diazepine.
ES2157887T3 (es) Compuestos heterociclicos que contienen azufre.
DE69520561D1 (de) Phenylborsaurekomplexe
ATE118769T1 (de) Benzotriazol-derivate und diese enthaltende fluoreszierende reagenzien.
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
DE69328408D1 (de) Herstellung von Borester
ES2072765T3 (es) Procedimiento para la obtencion de 5,6-dihidroxi-indolinas.
NO902813D0 (no) (1,2,3,4-tetrahydro-9-acridinimino)cykloheksankarboksylsyre og relaterte forbindelser, fremgangsmaate for fremstilling og anvendelse som medikamenter.
NO870176L (no) Nye forbindelser og fremgangsmaater.
DE59902638D1 (de) Verwendung von funktional substituierten Betainen als Antitranspirantien
NO173439C (no) Syntese av perfluoralkylbromider
ATE145911T1 (de) Inositol-phosphat-analog als kalzium- antagonistische substanz
DE59107456D1 (de) Verwendung von Phosphonsäurediglycidylestern als Vernetzer bei Hydrogelen
ATE375173T1 (de) Hydrophobe iodverbindung enthaltendes liposom und dieses enthaltendes röntgenkontrastmittel
ATE3751T1 (de) Wasserloesliche polyester und polycarbonate zur verwendung als antitumorwirkstoffe.
ATE5398T1 (de) Verfahren zur herstellung von polyoxaalkylierten oder polyoxaarylierten aminoalkohole und deren verwendung als komplexierungsmittel fuer katione.
DE58909089D1 (de) Verwendung von Myricetin-3-0-beta-D-glucuronid als Arzneimittel.
ES2036613T3 (es) Fungicidas que contienen aminocompuestos.
DE59200413D1 (de) Buntesalzgruppen aufweisende Organosiliciumverbindungen, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
ATE206699T1 (de) Uch-15-verbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties